We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Face Time With The Future

By AACC Staff
Posted on 27 Jun 2018
Print article
In their day-to-day work, clinical laboratorians often are intensely focused on the present moment: meeting turnaround time goals, calling clinicians with critical values, or troubleshooting instrument problems to make sure patients get the best care possible.

But in a broader sense, laboratory medicine always has been focused on the future. Laboratorians are known for being dissatisfied with the status quo and for continuously searching for ways to improve quality, refine measurements, or discover fresh answers to tough healthcare problems.

This dual citizenship in the present and the future explains why more than 20,000 people from all over the world gather every year at the AACC Annual Scientific Meeting & Clinical Lab Expo. Laboratorians crave new insights and meaningful connections that will nourish their natural curiosity—and professional zeal—to explore the field’s latest science and technology.

Importantly, the meeting means a lot more than just a place to process information. In an age when screen time seems ever more pervasive, a face-to-face conference offers authentic connections and an opportunity unlike any other for inspiration, refreshment, and discovery.

Here are a few ways to boost your in-person time with world-renowned experts and like-minded colleagues whom you won’t meet anywhere else.

1: POSTER WALKS

Those who have attended the AACC Annual Scientific Meeting before know that often the best way to meet colleagues and collaborators is during the poster sessions. But with nearly 1,000 posters, no one can see them all. One of the best ways to get a focused experience during the poster sessions is by attending a poster walk. Led by experts from one of AACC’s 20 scientific divisions, attendees tour posters by topic areas and participate in engaging discussions of study findings and methods. Check CLN Daily on-site for details.

2: ORAL ABSTRACT PRESENTATIONS

Each year, the Annual Meeting Organizing Committee hand-picks a series of outstanding abstracts for special oral presentations. Presenters will also be available at their posters during the poster sessions. There are six topics this year.

Monday, July 30
Global Health
Clinical Applications

Tuesday, July 31
Mass Spectrometry
Molecular Diagnostics and Genomics

Wednesday, August 1
Emerging Biomarkers and Technologies
Hot Topics in Lab Medicine

3: MEET THE EXPERTS

With attendance limited to 75 attendees, expect intensive, interactive discussions with plenary speakers Monday-Thursday of the conference. Show up early to these morning sessions and be ready with questions. Plenary speakers include:

Sunday, July 29
Brian Druker, MD: Imatinib as a Paradigm of Targeted Cancer Therapies

Monday, July 30
Kenneth Setchell, PhD: Genetic Defects in Bile Acid Synthesis—Translational Medicine from Mass Spectrometry Discovery to the Bedside

Tuesday, July 31
Denise Galloway, PhD: HPV Associated Cancers and the HPV Vaccine

Wednesday, August 1
James Collins, PhD: Nucleic Acid Detection Using CRISPR-Dx

Thursday, August 2
Timothy Amukele, MD, PhD, and Lee Schroeder, MD, PhD: Essential Diagnostics—Meeting the Needs of a Global Population

4: NEW FOR 2018: EXPLORE TOPIC TRACKS

Eight topic tracks provide paths through different areas of laboratory medicine and include both large symposia as well as more intimate brown bag sessions. Talking with fellow attendees after a symposium or during a brown bag session is a great way to gain real-world insights into the content.
• Endocrinology
• Genomics/Genetics
• Mass Spectrometry
• Pediatric/Maternal-Fetal
• Point-of-Care Testing
• Precision Medicine and Oncology
• Toxicology/Therapeutic Drug Monitoring
• Utilization and Lab Management

Visit AACC 2018 >>


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
cTnI/CK-MB/Myo Test
Finecare cTnI/CK-MB/Myo Rapid Quantitative Test
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.